Nonpharmacological Methods for Children

The population of this study consisted of the children within the age range of 7-12 years who applied to the injection room in the pediatrics clinic of a university hospital between November 2017 and June 2018. On the other hand, the sample of this study consisted of 150 children who met the case-selection criteria and agreed to participate in the study.

In the Power analysis carried out based on the literature, the sample size of the study was determined as 150 with the confidence level of 90% (α=0.10). For 150 children, the power was β=0.20, 1-β=0.80 with α =.05. The approximate number of subjects was calculated as 50 per group with the Cohen's effect size of α = .05 and the confidence interval of 95%. The children in the sample were randomly assigned to the following groups: Cold application, Shotblocker, and control. In order to determine which case to include in which group, the numbers were randomly distributed to the 3 groups without repetition using a software. In the study, the sample size for each of the 3 groups, that is, cold application group (n=50), Shotblocker group (n=50), and control group (n=50) was determined as 50.

The intramuscular injection was carried out in the pediatric injection room of a university hospital. Before the intervention, the parents and children were met, they were informed about the study, and they were asked whether they would accept to participate in the study. The written and verbal consent were obtained from the parents and the children, respectively. In order to ensure reliability in the study results, the intramuscular injection was applied by the same nurse having at least 5 years of working experience throughout the study; and the pain behavior and anxiety levels of the children were evaluated by the same researcher. The parents were allowed to stay with their children during the intramuscular injection.

The following information was obtained from the children and parents who agreed to participate in the study using the Child Information Form: the socio-demographic characteristics of the children and parent, the previous history of IM injection, the previous history of being subject to a painful intervention, whether the child took an analgesic drug within the last 6 hours, the body mass index (BMI), etc. Prior to the intramuscular injection, the children's weight and height were measured and recorded. The same medicine (procaine penicilline) was administered to all children.

During the intramuscular injection, it was ensured that the environmental factors (temperature, light, noise, etc.), the injection site, and the antiseptic solution (70% alcohol) were standardized. The injection site was wiped using an antiseptic (batticon/chlorhexidine) cotton by gently pressing from center to periphery. It was ensured that the child was in the appropriate position, that is, in the prone position, with the toes facing inward. Prior to the injection, Shotblocker or the cold gel pad was introduced to the children in the experimental group and they were informed of how they would be used. Furthermore, the children and parents were informed about the Wong-Baker FACES® Pain Rating Scale and Children's Fear Scale (CFS) to be used in the study. The parents and children who volunteered to take part in the study were informed of the scale scoring. Which parent would take part in the study was left to the choice of parents to take participate. The CFS scale was evaluated preoperatively after receiving consent from the children and parents and completing the information form. The pain evaluation was made by the children, parents, and observers right after the procedure. When applying the scales, a particular attention was paid so that the children, parents and observers would not see each other's evaluation and not affect one another. Before the injection, the anxiety level was evaluated by the child, parent, and researcher using Children's Fear Scale (CFS). After the injection; the pain level was evaluated by the child, parent, and researcher using the Wong-Baker FACES® Pain Rating Scale, and the anxiety level was evaluated by the parent and researcher using Children's Fear Scale (CFS).

The data of the study was collected using the Child Information Form, the Wong-Baker FACES® Scale, and Children's Fear Scale.

Child Information Form: This form was prepared by the researcher to get information about the children selected for the sample. This form contains a total of 12 questions such as socio-demographic characteristics of the children, whether the child has a health problem that affects her/his perception of pain, the previous history of IM injection, injection duration, and whether the child has injection fear, etc.

Wong-Baker FACES® Scale (WB-FACES): In this scale, there are six faces representing the pain in an increasing order of intensity from zero to five from left to right. The leftmost face has a smile on it, representing "no pain"; whereas the rightmost face has a crying expression, representing "the most intense pain." As the score obtained from the scale increases, the pain tolerance decreases, and vice versa. In practice, the child is asked to choose the face that best expresses her/his feelings. In the application of the scale, it is explained to the child that each face belongs to a person, and the faces represent a happy person with no pain or a sad person feeling a little or too much pain.

Children's Fear Scale (CFS): The scale is used to measure the levels of fear and anxiety in children. The child is shown a picture of 5 facial expressions, each having a score between "0" and "4" points. This scale can be easily applied by both researchers and families to measure the fear and anxiety before and during the applications. In the scale, while "0" refers to "no fear and anxiety"; "4" refers to "the highest fear and anxiety".

The data obtained in this study was analyzed using IBM SPSS Statistics 22 (IBM SPSS, Turkey). The fitness of the parameters to normal distribution was evaluated by the Shapiro-Wilks test. In the evaluation of the data, in addition to the descriptive statistical methods (Mean, Standard deviation, Frequency), one-way analysis of variance (ANOVA) test was used for the comparisons of three or more groups with normal distribution and Tamhane's T2 for the paired comparisons. On the other hand, Chi-Square test was used for the comparison of the qualitative data. The statistical significance was set at p<0.05.

Permission was obtained from the clinical research ethics committee (29.07.16 / 2016-41) to implement the study, and from the relevant institution to carry out the study. Before starting the research, all the children and parents were informed of the purpose of the study, how the study would be carried out, and how the data of the study would be used; and then their verbal and written consent were obtained through the Voluntary Informed Consent Form. Furthermore, they were informed that they could quit the study at any time without giving any reason.